Compare · CELZ vs RKT
CELZ vs RKT
Side-by-side comparison of Creative Medical Technology Holdings Inc. (CELZ) and Rocket Companies Inc. (RKT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELZ and RKT operate in Finance: Consumer Services (Finance), so they compete in similar markets.
- RKT is the larger of the two at $43.99B, about 5173.8x CELZ ($8.5M).
- Over the past year, CELZ is up 13.1% and RKT is up 23.7% - RKT leads by 10.6 points.
- RKT has been more active in the news (24 items in the past 4 weeks vs 1 for CELZ).
- RKT has more recent analyst coverage (25 ratings vs 1 for CELZ).
- Company
- Creative Medical Technology Holdings Inc.
- Rocket Companies Inc.
- Price
- $2.25-2.60%
- $15.60+2.03%
- Market cap
- $8.5M
- $43.99B
- 1M return
- +19.68%
- +9.17%
- 1Y return
- +13.07%
- +23.66%
- Industry
- Finance: Consumer Services
- Finance: Consumer Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 1
- 24
- Recent ratings
- 1
- 25
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
Rocket Companies Inc.
Rocket Companies, Inc. engages in the tech-driven real estate, mortgage, and eCommerce businesses in the United States and Canada. It operates in two segments, Direct to Consumer and Partner Network. The company's solutions include Rocket Mortgage, a mortgage lender; Amrock that provides title insurance, property valuation, and settlement services; Rocket Homes, a home search platform and real estate agent referral network, which offers technology-enabled services to support the home buying and selling experience; Rocket Auto, an automotive retail marketplace that provides centralized and virtual car sales support to national car rental and online car purchasing platforms; and Rocket Loans, an online-based personal loans business. Its solutions also include Core Digital Media, a digital social and display advertiser in the mortgage, insurance, and education sectors; Nexsys, a fintech company, which offers a suite of essential tech solutions for mortgage origination and closing processes through digitization and automation; Lendesk, a technology services company that provides a point of sale system for mortgage professionals and a loan origination system for private lenders; and Edison Financial, a digital mortgage startup. In addition, the company originates, closes, sells, and services agency-conforming loans. Rocket Companies, Inc. was founded in in 1985 and is headquartered in Detroit, Michigan. Rocket Companies, Inc. is a subsidiary of Rock Holdings, Inc.
Latest CELZ
- Amendment: SEC Form 10-K/A filed by Creative Medical Technology Holdings Inc.
- SEC Form 10-K filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline
- Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
- Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point
- SEC Form 424B3 filed by Creative Medical Technology Holdings Inc.
- SEC Form EFFECT filed by Creative Medical Technology Holdings Inc.
Latest RKT
- Stephens initiated coverage on Rocket Companies with a new price target
- Rocket Companies to Announce First Quarter 2026 Results on May 7, 2026
- Salt Lake City Ranks First Among Metros Where Gen Zers Own the Largest Share of 3+ Bedroom Homes
- More Homeowners Are Putting Up 'For Sale' Signs As the Days Get Warmer
- More Than 50,000 Home-Purchase Contracts Fell Through in March
- Redfin Reports U.S. Home Prices Inched Up 0.1% in March
- Late April Is the Best Time to List a Home For Sale
- Homebuyers Hold the Negotiating Power In 38 Major Metros, Up From 29 Last Year
- U.S. Homeowners Are Remodeling Instead of Relocating
- This Spring's Housing Market Is Unseasonably Slow As Iran War, High Costs Curb Demand